After treatment with 5 and 10 μmol/L ATRA, the VEGF mRNA transcript levels in glioma cells increased remarkably, compared with that in the control group, and the relative protein expression of VEGF was also up-regulated. This evidence concerns the gene VEGFA and central nervous system cancer.